Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Van Gorp

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmacology|January 20, 1987
Vasoconstrictor expression of human platelet-vessel wall interactions: inhibition by the Ca2+ entry blocker flunarizineJ M Van Nueten, W De Ridder, L Van Gorp, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1985
Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blockerF De Clerck, W Loots, Y Somers, et al.
Nephron|January 1, 1987
Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysisP De Deyn, B Marescau, W Lornoy, et al.
Journal of Pharmaceutical Sciences|July 1, 1994
New approaches for the preparation of hydrophobic heparin derivativesJ Liu, A Pervin, C M Gallo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1987
Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiencyP P De Deyn, B Marescau, J J Cuykens, et al.
Carbohydrate Research|October 16, 1995
Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparinC C Griffin, R J Linhardt, C L Van Gorp, et al.
Regional Anesthesia and Pain Medicine|August 12, 2004
Ropivacaine 3.75 mg/ml, 5 mg/ml, or 7.5 mg/ml for cervical plexus block during carotid endarterectomyVincent J Umbrain, Viola L van Gorp, Eric Schmedding, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
European Journal of Pharmacology|January 20, 1987
Vasoconstrictor expression of human platelet-vessel wall interactions: inhibition by the Ca2+ entry blocker flunarizineJ M Van Nueten, W De Ridder, L Van Gorp, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|March 1, 1985
Thromboxane A2-induced vascular endothelial cell damage and respiratory smooth muscle cell contraction: inhibition by flunarizine, a Ca2+-overload blockerF De Clerck, W Loots, Y Somers, et al.
Nephron|January 1, 1987
Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysisP De Deyn, B Marescau, W Lornoy, et al.
Journal of Pharmaceutical Sciences|July 1, 1994
New approaches for the preparation of hydrophobic heparin derivativesJ Liu, A Pervin, C M Gallo, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 30, 1987
Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiencyP P De Deyn, B Marescau, J J Cuykens, et al.
Carbohydrate Research|October 16, 1995
Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparinC C Griffin, R J Linhardt, C L Van Gorp, et al.
Regional Anesthesia and Pain Medicine|August 12, 2004
Ropivacaine 3.75 mg/ml, 5 mg/ml, or 7.5 mg/ml for cervical plexus block during carotid endarterectomyVincent J Umbrain, Viola L van Gorp, Eric Schmedding, et al.
Pageof 2